Scientist Home Future Health Limited (SHFH)
| Market Cap | 25.38M |
| Revenue (ttm) | 400.74K -15.5% |
| Net Income | -400.50K |
| EPS | -0.02 |
| Shares Out | 23.72M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 500 |
| Open | 1.520 |
| Previous Close | 1.700 |
| Day's Range | 1.070 - 1.520 |
| 52-Week Range | 1.070 - 12.000 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 11, 2026 |
About SHFH
Scientist Home Future Health Limited, through its subsidiaries, engages in the retail trading of health supplements and topical creams, and provides physical check-up services in Hong Kong. The company offers Scientist Home Vein Cream, Scientist Home Calcification Cream, Scientist Home Spermaceti Cream, Scientist Home Bone Gelatine Hydrolysate, Scientist Home Mixed Gelatine Hydrolysate, Scientist Home High Concentration Proteinase, and Scientist Home Cholipolysis Cholic Acid products. It also provides health consultations through nutrition spec... [Read more]
Financial Performance
Financial StatementsNews
Scientist Home Future Health Trial Demonstrates Significant Reduction in Eczema Symptoms using Evidence-based Nutritional Therapy
HONG KONG, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Scientist Home Future Health LTD (OTCID: SHFH) (Scientist home or ‘The Company') is pleased to announce Researchers at Scientist Home have announced promi...
Scientist Home Future Health Reports Second Quarter 2026 Financial Results
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Scientist Home Future Health LTD (OTCID: SHFH) today reported financial results for the three and six months ended June 30, 2026.